Literature DB >> 15342264

Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain.

Evangelia Spandou1, Stamatia Papoutsopoulou, Vassiliki Soubasi, George Karkavelas, Constantina Simeonidou, George Kremenopoulos, Olympia Guiba-Tziampiri.   

Abstract

Erythropoietin (EPO), known for its role in erythroid differentiation, has been suggested to have non-hematopoietic functions in the brain, especially during development. In the present study, we investigated the expression of erythropoietin and erythropoietin receptor (EPOR) in the developing rat brain following hypoxia-ischemia. Seven-day-old rats underwent unilateral, permanent carotid artery ligation followed by 1 h of hypoxia, and their brains were examined immediately, 24 h or 4 days after hypoxia-ischemia. RT-PCR and Western blot analysis revealed that hypoxia-ischemia only marginally affected EPO expression. Immunohistochemical study of brains 4 days after hypoxia showed that 60 min of hypoxia (resulting in cortical infarction and severe neuronal loss in other regions) led to the increased EPO immunoreactivity, especially in the boundaries of the damaged cerebral cortex, associated with astrocytosis. In contrast, EPOR was dramatically upregulated within 24 h after hypoxia-ischemia. These results suggest that there is a rapid response of EPOR to the hypoxic-ischemic stimulus, which seems to precede that of EPO, leading to the hypothesis that the EPO/EPOR system is implicated in the processes of neuroprotection from hypoxia-ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342264     DOI: 10.1016/j.brainres.2004.06.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

Authors:  Vijayeta Rangarajan; Sandra E Juul
Journal:  Pediatr Neurol       Date:  2014-06-24       Impact factor: 3.372

2.  Hypoxic Ischemic Encephalopathy: Pathophysiology and Experimental Treatments.

Authors:  Kimberly A Allen; Debra H Brandon
Journal:  Newborn Infant Nurs Rev       Date:  2011-09-01

3.  Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.

Authors:  Shenandoah Robinson; Christopher J Corbett; Jesse L Winer; Lindsay A S Chan; Jessie R Maxwell; Christopher V Anstine; Tracylyn R Yellowhair; Nicholas A Andrews; Yirong Yang; Laurel O Sillerud; Lauren L Jantzie
Journal:  Exp Neurol       Date:  2017-12-26       Impact factor: 5.330

4.  Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia.

Authors:  Monica Fantacci; Paola Bianciardi; Anna Caretti; Thomas R Coleman; Anthony Cerami; Michael Brines; Michele Samaja
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

5.  The Differential Effects of Erythropoietin Exposure to Oxidative Stress on Microglia and Astrocytes in vitro.

Authors:  Praneeti Pathipati; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2017-05-17       Impact factor: 2.984

6.  Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.

Authors:  Jing Chen; Kip M Connor; Christopher M Aderman; Keirnan L Willett; Oskar P Aspegren; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

7.  Erythropoietin sustains cognitive function and brain volume after neonatal stroke.

Authors:  Fernando F Gonzalez; Regina Abel; C Robert Almli; Dezhi Mu; Michael Wendland; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2009-08-11       Impact factor: 2.984

8.  Evidence of receptor-mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia.

Authors:  Demet Nalbant; Mohammad Saleh; Frederic D Goldman; John A Widness; Peter Veng-Pedersen
Journal:  J Pharmacol Exp Ther       Date:  2010-01-26       Impact factor: 4.030

9.  Nanoparticle facilitated inhalational delivery of erythropoietin receptor cDNA protects against hyperoxic lung injury.

Authors:  Priya Ravikumar; Jyothi U Menon; Primana Punnakitikashem; Dipendra Gyawali; Osamu Togao; Masaya Takahashi; Jianning Zhang; Jianfeng Ye; Orson W Moe; Kytai T Nguyen; Connie C W Hsia
Journal:  Nanomedicine       Date:  2015-10-27       Impact factor: 5.307

10.  Erythropoietin in brain development and beyond.

Authors:  Mawadda Alnaeeli; Li Wang; Barbora Piknova; Heather Rogers; Xiaoxia Li; Constance Tom Noguchi
Journal:  Anat Res Int       Date:  2012-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.